- Home
- CHR vs GTBP Comparison
CHR vs GTBP Comparison
Compare CHR & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHR
- GTBP
- Stock Information
- Founded
- CHR 2016
- GTBP 1965
- Country
- CHR China
- GTBP United States
- Employees
- CHR N/A
- GTBP N/A
- Industry
- CHR EDP Services
- GTBP Biotechnology: Pharmaceutical Preparations
- Sector
- CHR Technology
- GTBP Health Care
- Exchange
- CHR Nasdaq
- GTBP Nasdaq
- Market Cap
- CHR 2.5M
- GTBP 2.6M
- IPO Year
- CHR N/A
- GTBP N/A
- Fundamental
- Price
- CHR $0.12
- GTBP $0.60
- Analyst Decision
- CHR
- GTBP Strong Buy
- Analyst Count
- CHR 0
- GTBP 1
- Target Price
- CHR N/A
- GTBP $11.00
- AVG Volume (30 Days)
- CHR 34.1M
- GTBP 4.5M
- Earning Date
- CHR 07-30-2025
- GTBP 11-13-2025
- Dividend Yield
- CHR N/A
- GTBP N/A
- EPS Growth
- CHR N/A
- GTBP N/A
- EPS
- CHR 1.92
- GTBP N/A
- Revenue
- CHR $147,134,000.00
- GTBP N/A
- Revenue This Year
- CHR N/A
- GTBP N/A
- Revenue Next Year
- CHR N/A
- GTBP N/A
- P/E Ratio
- CHR $0.07
- GTBP N/A
- Revenue Growth
- CHR N/A
- GTBP N/A
- 52 Week Low
- CHR $0.11
- GTBP $0.55
- 52 Week High
- CHR $3.45
- GTBP $4.10
- Technical
- Relative Strength Index (RSI)
- CHR 23.42
- GTBP 39.53
- Support Level
- CHR $0.12
- GTBP $0.65
- Resistance Level
- CHR $0.14
- GTBP $0.78
- Average True Range (ATR)
- CHR 0.01
- GTBP 0.07
- MACD
- CHR 0.03
- GTBP 0.00
- Stochastic Oscillator
- CHR 14.93
- GTBP 5.37
About CHR Cheer Holding Inc.
Cheer Holding Inc is a provider of next generation mobile internet infrastructure and platform services in China. It is engaged in building a digital ecosystem that integrates platforms, applications, technology, and industry into a cohesive system, thereby creating a new, open business environment that leverages AI technology. Its portfolio includes various products and services, such as Polaris Intelligent Cloud, CHEERS Telepathy, CHEERS Open Platform, CHEERS Video, CHEERS e-Mall, CheerReal, CheerCar, CheerChat, CHEERS Fresh Group-Buying E-commerce Platform, Digital Innovation Research Institute, CHEERS Livestreaming, variety show series, IP short video matrix, and more.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.